Method of treating wounds by enhancing expression of procollagen
The present invention provides methods for identifying compounds useful for the treatment of wounds by determining whether the compound increases the expression of type I procollagen and/or type III procollagen by human fibroblasts cultured in the presence of collagen. The present invention also provides methods for treating wounds by applying to the wound and/or surrounding tissue a therapeutically effective amount of anabolic steroid in a pharmaceutically acceptable formulation, wherein the steroid is not administered systemically to a patient. The present invention also provides compositions comprising at least one anabolic steroid in an amount effective to promote collagen production in at the site of a wound, wherein the composition is a pharmaceutically acceptable formulation suitable for local administration.
1 . A method for identifying a compound useful for the treatment of wounds comprising determining whether the compound increases the expression of type I procollagen and/or type III procollagen by human fibroblasts cultured in the presence of collagen.
2 - 73 . (canceled)
74 . The method of claim 1 , further comprising determining whether the compound does not substantially increase the expression of type I procollagen and/or type III procollagen by human fibroblasts cultured in the presence of plastic.
75 . The method of claim 1 or 74 , wherein the compound increases the expression of type I procollagen about two-fold.
76 . The method of claim 1 or 74 , wherein the compound increases the expression of type III procollagen about eleven-fold.
77 . The method of claim 1 or 74 , wherein the compound increases the expression of type I procollagen about two-fold and increases the expression of type III procollagen about eleven-fold.